Published Date: August, 2017
Global clinical chemistry analyzer market is expected to be driven by rapid growth in diagnostic market, increased spending in healthcare and augmented incidents in life style diseases. Additionally, technological advancements, increased awareness of healthcare and diagnostic tests amongst population are likely to support the growth in the global market.
Clinical chemistry analyzers are the computers programmed devices used to determine and analyze levels of sugar, protein, and sugar present in the blood. These devices bring precise result at possible least time, because they are highly technologically advance and made for such purpose. Clinical chemistry tests are performed to determine clinical situations including kidney function, liver function, and nutritional state. Furthermore, these tests are commonly adopted to analyze clinical conditions such as hyperlipidemia, diabetes, and arteriosclerosis. The report provides inclusive analysis of market volume covered by the clinical chemistry analyzer across the world. The global market size of clinical chemistry analyzer was worth approximately USD 9 billion in 2014 and the global market is forecast to surpass USD X.X billion by 2023. Moreover, clinical analyzer market is anticipated grow at a CAGR between 5.1% - 5.5% over the period of 2017 to 2023.
Figure: Global Clinical Chemistry Analyzer Market by Value 2015 – 2023
Global clinical chemistry analyzer market is expected to be driven by rapid growth in diagnostic market, increased spending in healthcare and augmented incidents in life style diseases. Additionally, technological advancements, increased awareness of healthcare and diagnostic tests amongst population are likely to support the growth in the global market. Similarly, rising number of point of care testing capabilities are also expected to boost the growth of this market over the forecast period. Moreover, usage of clinical chemistry analyzers in investing crimes is likely to boost the market size of the clinical chemistry analyzers in the world market with rising number of crimes globally. However, high cost, and requirement of highly qualified and trained personnel are some of the restraints that are likely to hamper the growth in this market over the forecast period. Geographically, the North America is considered as the leading market and accounted for 60% in the market in 2014. Emerging markets such as BRIC countries are likely to grow at the fastest CAGR over the forecast period. The report covers the analysis of global as well as regional markets of clinical chemistry analyzer market.
Geographic Coverage and Analysis:
The global clinical chemistry analyzer market is segmented geographically as North America, Europe, BRIC and Rest of the World (which includes Japan and Australia). Moreover the report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand globally as well as regionally. Moreover, Infinium Global Research- Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider.
The companies covered in the report include Roche Diagnostics, Beckman Coulter, Abbott Diagnostics, Siemens AG, Johnson and Johnson, Ortho-Clinical Diagnostics, Thermo Fisher Scientific, Randox Laboratories Ltd., Elitech Group, Mindray Medical International Ltd, Horiba Ltd.
The report also provides in depth analysis of regulatory framework pertaining to Clinical Chemistry Analyzer Market. This will help the companies to understand the regulatory compliances, supports, barriers in the Clinical Chemistry Analyzer market. This section highlights key amendments and their implication on Clinical Chemistry Analyzer market in the short run as well as in the long run.
The report provides insights into the market using analytical tools such as Porter’s five forces analysis and value chain analysis of Clinical chemistry analyzers. Moreover, the study highlights current market trends and provides forecast from 2017 to 2023. We also have highlighted future trends in the clinical chemistry analyzer market that will impact the demand during the forecast period.
The Infinium Global Research- Growth Matrix analysis provided in this report highlights key investing markets in the world. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market.
1.1. Report Description
1.2. Research Method
1.3. Product and Market Segmentation.
2. Executive Summary
2.1 clinical chemistry analyzer market highlights –clinical chemistry analyzer market share (USD million)
3. Clinical Chemistry Analyzer Market Dynamics
3.2. Market dynamics
3.3. Porter’s five forces analysis
3.4. IGR-Growth matrix analysis
3.5. Competitive landscape in the Clinical Chemistry Analyzer Market, 2017 – 2023
3.6 . Regulatory Framework Analysis by Region
3.6.1 North America
3.6.3 RoW (Including APAC, and LATAM)
4. Clinical Chemistry Analyzer Market by Product
4.1.1. By Size
18.104.22.168. Small (400-800 Test/H)
22.214.171.124. Medium (400-800Test/h)
126.96.36.199. Large (1200-2000 Test/H)
188.8.131.52. Very large (2000test/H)
4.2.4. Other reagent
5. Clinical Chemical Analyzer Market by Test
5.1. Basic Metabolic Panel
5.2. Electrolyte Panel
5.3. Liver Panel
5.4. Lipid Profile
5.5. Renal Profile
5.6. Thyroid Function Panel
5.7. Specialty Chemicals
6. Clinical Chemical Analyzer Market by End User
6.1. Academic Research Institutes
6.2. Diagnostics Laboratories
6.4. Other End Users
7. Clinical Chemical Analyzer Market by Region
7.1. North Americas
7.4. Rest of the World (RoW)
8. Company Profile
8.1. Roche Diagnostics
8.2. Beckman Coulter
8.3. Abbott Diagnostics
8.4. Siemens AG
8.5. Johnson and Johnson
8.6. Ortho-Clinical Diagnostics
8.7. Thermo Fisher Scientific
8.8. Randox Laboratories Ltd.
8.9. Elitech Group
8.10. Mindray Medical International Ltd
8.11. Horiba Ltd